On the Ground in Malawi-First Typhoid Conjugate Vaccine Study in Africa

The Typhoid Vaccine Acceleration Consortium (TyVAC) is led by the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, the Oxford Vaccine Group at the University of Oxford, and PATH. The Typhoid Vaccine Acceleration Consortium is funded by the Bill &...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of tropical medicine and hygiene 2019-06, Vol.100 (6), p.1299-1300
Hauptverfasser:	Patel, Pratiksha, Patel, Priyanka, Meiring, James E, Misiri, Theresa, Mwakiseghile, Felistas, Gordon, Melita A
Format:	Artikel
Sprache:	eng
Schlagworte:	Child Child, Preschool Consortia Female Humans Malawi - epidemiology Male Mass Vaccination - ethics Mass Vaccination - methods Salmonella typhi - immunology Salmonella typhi - pathogenicity Schools Stories from the Field Typhoid Typhoid Fever - epidemiology Typhoid Fever - immunology Typhoid Fever - microbiology Typhoid Fever - prevention & control Typhoid-Paratyphoid Vaccines - administration & dosage Vaccination Coverage - statistics & numerical data Vaccines Vaccines, Conjugate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The Typhoid Vaccine Acceleration Consortium (TyVAC) is led by the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, the Oxford Vaccine Group at the University of Oxford, and PATH. The Typhoid Vaccine Acceleration Consortium is funded by the Bill & Melinda Gates Foundation. This study is part of the TyVAC, a partnership between the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, the Oxford, and PATH. This vaccine efficacy study is the biggest of its kind to ever be conducted in Blantyre Malawi.
ISSN:	0002-9637 1476-1645
DOI:	10.4269/ajtmh.19-0014